摘要
目的:探讨miR-125b靶向调控HK2对乳腺癌MCF-7细胞放射敏感性的影响。方法:将miR-125b模拟物及其阴性对照转染至乳腺癌MCF-7细胞,分别记为miR-125b组和miR-NC组,采用RT-PCR检测MCF-7细胞中miR-125b和HK2mRNA的表达,Western blotting检测HK2蛋白的表达;双荧光素酶报告基因实验检测miR-125b和HK2的靶向关系。另外将miR-125b模拟物和pcDNA3.1-HK2质粒共转染至MCF-7细胞中,记为miR-125b+HK2组,通过克隆形成实验和流式细胞仪检测miR-NC组、miR-125b组和miR-125b+HK2组细胞的存活分数和凋亡率。结果:与miR-NC组相比,转染miR-125b模拟物后MCF-7细胞中miR-125b表达升高(P<0.01),而HK2mRNA和蛋白的表达降低(P<0.01)。双荧光素酶报告基因实验证实HK2是miR-125b的潜在靶基因。与miR-NC组相比,miR-125b组细胞的存活分数降低、凋亡率升高(P<0.01);与miR-125b组相比,miR-125b+HK2组存活分数降低明显升高而凋亡率降低(P<0.01)。结论:miR-125b可通过靶向调控HK2表达增强乳腺癌MCF-7细胞的放射敏感性。
Objective:To investigate the effects of miR-125b targeting HK2 expression on the radiosensitivity of breast cancer MCF-7 cells. Methods:The miR-125b mimics and its negative control were transfected into breast cancer MCF-7 cells,and divided into the miR-125b group and miR-NC group,respectively.The expression levels of miR-125b and HK2 mRNA in MCF-7 cells were detected using RT-PCR,and the expression of HK2 protein was detected by Western blotting.The targeting relationship between miR-125b and HK2 was detected using double luciferase reporter gene assay.The mimic of miR-125b and pcDNA3.1-HK2 plasmid were co-transfected into MCF-7 cells(miR-125b+HK2 group),and the survival fraction and apoptotic rate of cells in three groups were detected by clone formation assay and flow cytometry. Results:After transfecting miR-125b mimics,compared with the miR-NC group,the expression level of miR-125b in MCF-7 cells increased( P <0.01),and the expression levels of HK2 mRNA and protein decreased ( P < 0.01).The results of double luciferase reporter gene assay confirmed that the HK2 was a potential target gene of miR-125b.Compared with the miR-NC group,the survival fraction and apoptotic rate of cells in miR-125b group decreased and increased,respectively( P < 0.01).Compared with the miR-125b group,the survival fraction and apoptotic rate in miR-125b + HK2 group significantly increased and decreased,respectively( P <0.01). Conclusions:MiR-125b can enhance the radiosensitivity of breast cancer MCF-7 cells by targeting HK2 expression.
作者
焦玮
魏凌
胡明明
李建国
JIAO Wei;WEI Ling;HU Ming-ming;Li Jian-guo(Department of Radiology,The Affiliated Hospital of Qingdao University,Qingdao Shandong 266000,China;Department of Respiratory,The Affiliated Hospital of Qingdao University,Qingdao Shandong 266000,China;Department of Radiotherapy,The Affiliated Hospital of Qingdao University,Qingdao Shandong 266000,China;Breast Center,The Affiliated Hospital of Qingdao University,Qingdao Shandong 266000,China)
出处
《蚌埠医学院学报》
CAS
2019年第9期1158-1162,共5页
Journal of Bengbu Medical College
基金
山东省自然科学基金资助项目(ZR2016HL084)